5,7-Di-tert-butyl-3-phenylbenzo[d]oxazol-3-ium Tetrafluoroborate (CAS 1207294-92-5)

Product Summary: This compound is a high-purity pharmaceutical intermediate manufactured by Haohong (Qihe) Pharmaceutical Technology Co., Ltd. It is used in pharmaceutical manufacturing, particularly in the synthesis of active pharmaceutical ingredients. With a molecular formula of C21H26BF4NO and molecular weight of 395.25, it meets the rigorous standards required for R&D and custom production.

Key Selling Points

• High Purity: Produced under ISO 9001:2015 certified quality management system, ensuring consistent quality for sensitive pharmaceutical applications.
• Custom Synthesis Capability: Available in quantities from gram scale to hundreds of kilograms, supporting both R&D and commercial production.
• Expert R&D Team: Backed by a team of 30 engineers, enabling technical support and custom modifications.
• Proven Export Experience: Exported to markets including the US, Europe, Japan, and India, indicating global acceptance.

Technical Specifications

Models and Options

This is the standard grade. Custom packaging and batch sizes are available upon request.

Materials and Structure

The compound consists of a benzoxazolium cation with tert-butyl groups at positions 5 and 7, phenyl at position 3, paired with tetrafluoroborate anion.

Applications

Mainly used in the pharmaceutical manufacturing industry as an intermediate for synthesizing APIs, especially in anti-cancer and other therapeutic areas.

Customization

We offer custom synthesis from gram to hundreds of kilograms scale. Contact us for specific requirements.

FAQ

Inquiry Information

For more details, contact:
Name: Xu Tianxia
Email: Xutx@haohong-pharma.com
Tel/WhatsApp: +86 180-6854-1569
Company: Haohong (Qihe) Pharmaceutical Technology Co., Ltd.

Image